Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹535.50Admitted-Finance 1003 1005 VISHAL TOWER DISTRICT CENTRE JANAK PURI NEW DELHI DELHI 110058 | WEST DELHI | DELHI | 110058 | ₹535.50 | L1 | Admitted-Finance |
| 2 | L2₹2,662.80+₹2,127.30 (397.3%)Admitted-Finance | ₹2,662.80+₹2,127.30 (397.3%) | L2 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Medikon India L2 | SMPL Life Sciences Pvt. Ltd. L1 |
|---|---|---|---|---|---|
| 1.00ENDO & GEN MED | |||||
| 1.01 | INSULIN DEGLUDEC 100 IU PER ML (HUMAN LONG ACTING ANALOGUE )3 ML PER PFS | 4,000 | PFS | 1,480 ₹1,554 Lowest | - |
| 2.01 | Insulin Degludec/Insulin Aspart 100 IU Per ml (70% Soluble insulin Degludec Plus 30% Soluble Insulin Aspara)3 ml Per PFS | 2,500 | PFS | 1,056 ₹1,108.8 Lowest | - |
| 3.01 | Inj Insulin Lispro 100 IU/ml (Recombinant DNA Origin) 3 ML PFS/PFS/CART | 2,000 | PFS/CART | - | 510 ₹535.5 Lowest |
| 4.01 | Tab Axitinib 5 mg | 476 | No | - | - |
Tender Value
Refer Docs
EMD Value
₹3.3 L
Closing Date
28 Aug 2020, 6:00 pmClosed
Commandant
CH (WC) Chandimandir
Procurement of Gen Med
2020_ARMY_369146_1
CHWC/IFA/ECHS/Endo and Gen Med/43/20-21
Open Tender
Medical Equipments/Waste
Buy
28 days
CH (WC) Chandimandir
Please refer Tender documents.
2 documents required · 2 mandatory
₹0
₹3.3 L
8 Oct 2020
14 Aug 2020
29 Aug 2020
14 Aug 2020
28 Aug 2020
14 Aug 2020
14 Aug 2020 - 27 Aug 2020
ENDO & GEN MED
INSULIN DEGLUDEC 100 IU PER ML (HUMAN LONG ACTING ANALOGUE )3 ML PER PFS
Insulin Degludec/Insulin Aspart 100 IU Per ml (70% Soluble insulin Degludec Plus 30% Soluble Insulin Aspara)3 ml Per PFS
Inj Insulin Lispro 100 IU/ml (Recombinant DNA Origin) 3 ML PFS/PFS/CART
Tab Axitinib 5 mg
Medikon India
SMPL Life Sciences Pvt. Ltd.
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .